Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study.

Daniele PastoriEvaristo EttorreGregory Y H LipAngela SciacquaFrancesco PerticoneFrancesco MelilloCosmo GodinoRossella MarcucciMartina BerteottiFrancesco VioliPasquale PignatelliMirella SaliolaDanilo MenichelliMarco Antonio CasciaroVito Menafra

Published in: British journal of clinical pharmacology (2020)

Patients prescribed NOACs showed a lower decline of renal function compared to those prescribed VKAs. This effect was partially lost in patients with diabetes.

Keyphrases

oral anticoagulants
end stage renal disease
atrial fibrillation
chronic kidney disease
newly diagnosed
ejection fraction
clinical trial
peritoneal dialysis
study protocol
cross sectional
patient reported outcomes